CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-01 | GUSSIN ROBERT Z Director | Option exercise · Stock Option (Right to Buy) | −2,142 | $16.66 | $36K | 0 |
| 2023-05-01 | GUSSIN ROBERT Z Director | Option exercise · Stock Option (Right to Buy) | −3,571 | $16.66 | $59K | 0 |
| 2023-05-01 | GUSSIN ROBERT Z Director | Option exercise · Stock Option (Right to Buy) | −3,571 | $19.60 | $70K | 0 |
| 2023-03-07 | O DONNELL MICHAEL J Director | Option exercise | +3,571 | $16.66 | $59K | 8,441 |
| 2023-03-07 | O DONNELL MICHAEL J Director | Option exercise | +3,571 | $19.60 | $70K | 12,012 |
| 2023-03-07 | O DONNELL MICHAEL J Director | Shares withheld for taxes | −2,361 | $25.20 | $59K | 9,651 |
| 2023-03-07 | O DONNELL MICHAEL J Director | Shares withheld for taxes | −2,778 | $25.20 | $70K | 6,873 |
| 2023-03-07 | O DONNELL MICHAEL J Director | Option exercise · Stock Option (Right to Buy) | −3,571 | $19.60 | $70K | 0 |
| 2023-03-07 | O DONNELL MICHAEL J Director | Option exercise · Stock Option (Right to Buy) | −3,571 | $16.66 | $59K | 0 |
| 2023-03-07 | Barry Richard Director | Purchase | +77,276 | $25.76 | $2.0M | 275,000 |
| 2023-03-06 | Barry Richard Director | Purchase | +11,565 | $26.13 | $302K | 197,724 |
| 2022-10-28 | Cook Robert Christopher SVP & General Counsel | Grant or award · Employee Stock Option (right to buy) | +100,000 | $36.76 | $3.7M | 100,000 |
| 2022-10-03 | FRIEDMANN NADAV Chief Medical Officer | Option exercise | +9,376 | $0.95 | $9K | 79,910 |
| 2022-10-03 | FRIEDMANN NADAV Chief Medical Officer | Option exercise · Common Stock | −9,376 | $0.95 | $9K | 40,624 |
| 2022-09-08 | ROBERTSON SANFORD Director | Option exercise | +2,802 | $23.59 | $66K | 1,027,567 |
| 2022-09-08 | ROBERTSON SANFORD Director | Option exercise · Common Stock | −2,802 | $23.59 | $66K | 0 |
| 2022-08-23 | Barry Richard Director | Purchase | +36,159 | $23.79 | $860K | 186,159 |
| 2022-08-23 | Kupiec James William Chief Clinical Dev. Officer | Purchase | +2,500 | $24.44 | $61K | 2,500 |
| 2022-08-12 | Schoen Eric Chief Financial Officer | Purchase | +2,500 | $19.95 | $50K | 19,800 |
| 2022-08-12 | ROBERTSON SANFORD Director | Purchase | +100,000 | $20.69 | $2.1M | 1,024,765 |
Page 6 of 17 · 324 trades